An evidence summary of the management of the care of patients taking novel oral antiplatelet drugs undergoing dental surgery

摘要

Background. Novel oral antiplatelet (NOAP) drugs (prasugrel and ticagrelor) have emerged in the past decade to overcome some of the drawbacks of existing medications. Little is known, however, regarding the management of the dental care of patients taking these drugs. The author of this study reviewed the available literature to assess the evidence for the management of the care of patients undergoing dental surgery while taking these medications.